This HTML5 document contains 181 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n6http://dx.doi.org/10.1158/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34168530
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel 2010年论文 научни чланак 2010年论文 научна статия tudományos cikk სამეცნიერო სტატია article scientifique (publié 2010) ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2010年論文 2010년 논문 vědecký článek مقالة علمية vitenskapelig artikkel scientific article artículu científicu espublizáu en 2010 article científic 2010年论文 articolo scientifico מאמר מדעי videnskabelig artikel (udgivet 2010) 2010年論文 vitskapeleg artikkel mokslinis straipsnis 2010 nî lūn-bûn bài báo khoa học artikulong pang-agham articol științific 2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած artigo científico (publicado na 2010) 2010 թվականի օգոստոսին հրատարակված գիտական հոդված 2010年论文 научная статья научни чланак سائنسی مضمون 2010年論文 2010年论文 artykuł naukowy wissenschaftlicher Artikel artigo científico bilimsel makale vetenskaplig artikel article scientific 2010年论文 บทความทางวิทยาศาสตร์ мақолаи илмӣ مقالهٔ علمی artículo científico publicado en 2010 2010年の論文 tieteellinen artikkeli наукова стаття, опублікована в серпні 2010 επιστημονικό άρθρο artigo científico (publicado na 2010) 2010年論文 scienca artikolo vedecký článok naučni članak 2010年論文 teaduslik artikkel мақолаи илмӣ artikull shkencor
p:P577
wds:Q34168530-C69CCA9F-70D2-48D4-90F4-D82EA8658EBE
wdt:P577
2010-08-12T00:00:00Z
p:P407
wds:Q34168530-DDCABE42-94A6-428C-B7E6-E2CF1DAA867B
wdt:P407
wd:Q1860
p:P2860
wds:Q34168530-934AD84B-2B4B-4055-AA15-6AB1C7F124D4 wds:Q34168530-9B21F7DE-2EBD-41A8-99FA-410CE9CC7F99 wds:Q34168530-A569CD75-0949-48C9-AE75-C440567A4C8F wds:Q34168530-8092233A-4941-4CA2-B388-8335C8AE8992 wds:Q34168530-83AEAD72-0E69-439F-BE4C-059199BB9F50 wds:Q34168530-61F16C74-C3E4-4EE6-A38B-EA618C74DF9F wds:Q34168530-62B15201-29D7-4786-9D7A-5C7A6D0FE8B8 wds:Q34168530-3FCFF712-91BC-4E7F-BA63-A989D8BAC6F9 wds:Q34168530-4CC30591-8C46-4115-871A-B7E7F620F2DA wds:Q34168530-546B2DB7-7FFC-4B9B-96F6-78AAC8507272 wds:Q34168530-5E100B81-7C9E-49E8-BE57-DB40A10D32D7 wds:Q34168530-2AFB25E6-59E5-4B26-B620-C08D9199AED4 wds:Q34168530-2D779A72-EE2A-4941-A673-2CA84595E8A8 wds:Q34168530-32A27FDB-09A4-4662-A731-DE8F6CCA8E22 wds:Q34168530-33BE1A9F-E0E2-4DB5-8DAC-DCB586DE9FD4 wds:Q34168530-1476C2DA-BF63-45C7-AD18-491EC9AE7B51 wds:Q34168530-26F6DCFD-A640-4036-8062-A9F502E55A4A wds:Q34168530-01446D67-DB5C-48F2-AC79-CAD7472D5708 wds:Q34168530-10D56FD1-5FE1-470D-93BE-FE87C147BFCB wds:Q34168530-1143141D-E277-4C74-B1A8-777E173D9575 wds:Q34168530-12B0068A-D063-4628-86D0-3C993214F700 wds:Q34168530-FD502785-237C-4945-B002-1044D64AA282 wds:Q34168530-E9E31745-9355-456F-824E-2119D478E82D wds:Q34168530-EE396AEC-8C60-4B4E-B532-201EA288AD1C wds:Q34168530-F1084ADE-9056-4248-8927-A919EF81D68E wds:Q34168530-D99D9F1B-C1EA-46CA-AB6F-992B14A911C8 wds:Q34168530-DBC9109F-FDFE-42BC-8410-B57E1B14DBDE wds:Q34168530-E9A4151E-84BD-4B5B-B819-1FFC014A128E wds:Q34168530-D063CB21-EE2C-4BC7-8A15-F869232ED086 wds:Q34168530-D3593F43-49EC-4035-AA1B-05D951B1BCE8 wds:Q34168530-C2DC61B8-DE05-4046-90A2-FB1A3CFEA067 wds:Q34168530-C4FDB271-3C76-4E13-8047-9AF815437E4A wds:Q34168530-C70A8ECD-26E7-4725-89FD-71183A4B7B82 wds:Q34168530-B4CF3039-4389-4DD3-83AF-2A0675AAFD03 wds:Q34168530-B68A2039-8D86-4CBE-9EBE-05FBE12F68B6 wds:Q34168530-B6CCCE00-4704-4816-8480-BE7406636583 wds:Q34168530-A7E2314C-CFB0-45EB-83FC-E1C2F1A4ACF3 wds:Q34168530-AB2BC7B2-1CE6-40FC-BB78-A4E17A601C37 wds:Q34168530-AE6DF471-2B8A-47EA-BA48-155D4FBDE323
wdt:P2860
wd:Q36983649 wd:Q80358623 wd:Q34968336 wd:Q27860904 wd:Q48164021 wd:Q39868741 wd:Q44897188 wd:Q37453782 wd:Q35842899 wd:Q33356908 wd:Q36408642 wd:Q82321820 wd:Q37357412 wd:Q40692665 wd:Q28476288 wd:Q28574271 wd:Q40298060 wd:Q35761437 wd:Q35188411 wd:Q34112975 wd:Q34570082 wd:Q33183932 wd:Q40336852 wd:Q34981120 wd:Q28475128 wd:Q46208195 wd:Q69407491 wd:Q40562999 wd:Q40126767 wd:Q46835743 wd:Q40035691 wd:Q53829627 wd:Q33658203 wd:Q29617273 wd:Q40211424 wd:Q39966583 wd:Q40617392 wd:Q34044072 wd:Q36045533
p:P2093
wds:Q34168530-FEAE3FE0-68F1-4EC5-AECC-20EFD415AC09 wds:Q34168530-7EAE97CB-5382-498C-A002-1BA6C338E098
wdt:P2093
Daniel L Gustafson Luke A Wittenburg
rdfs:label
Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer. Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer. Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer.
skos:prefLabel
Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer. Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer. Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer.
schema:name
Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer. Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer. Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer.
p:P50
wds:Q34168530-AE997CDD-628B-4BD8-99CD-B44D50866997
wdt:P50
wd:Q61937615
p:P1476
wds:Q34168530-8992390B-BF4A-4AAC-B7ED-CBEC9FCA97CC
wdt:P1476
Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer
p:P304
wds:Q34168530-A210500E-B571-4AE6-B66A-12B7DE8488AF
wdt:P304
4832-4842
p:P31
wds:Q34168530-6DDAB693-28E6-4F87-9EDB-7A0782C8654C
wdt:P31
wd:Q13442814
p:P698
wds:Q34168530-C7D26EB8-E999-48A8-9759-F240E728A9D6
wdtn:P698
n11:20705615
wdt:P698
20705615
p:P1433
wds:Q34168530-B98BE2BC-A60A-4603-9D6B-A611D5567BF5
wdt:P1433
wd:Q332253
p:P433
wds:Q34168530-D233EC39-FE7D-4552-99B2-090C91D8DFA0
p:P478
wds:Q34168530-FA487129-BC9B-4703-B56C-AF4C2EE686DD
wdt:P433
19
wdt:P478
16
p:P356
wds:Q34168530-27898409-5B19-4482-9C43-AB9B869EEC83
wdtn:P356
n6:1078-0432.CCR-10-1238
wdt:P356
10.1158/1078-0432.CCR-10-1238
p:P8608
wds:Q34168530-1897A0FE-33B5-48CC-879F-13669C73642A
wdt:P8608
release_3asfyj744vdbll6fkhh6l5azrq
p:P932
wds:Q34168530-6CB52FDD-2111-4B2B-ABC4-2F115959921A
wdt:P932
2948605